The NanoBusiness Alliance today announced that Vice President Vincent Caprio will be participating in the debut of The Livingston Healthcare & Life Science Stakeholders Summit - "Capturing Trends and Global Outlook: Advanced and Nano Technologies,” being held on September 10, 2008 at the Renaissance Hotel Times Square in New York City.
"Over the past three years, the Axiom Capital Management/Livingston Nanotechnology Conference has emerged as an important gathering for the investment community and pioneers in the area of nanotechnology,” said Vincent Caprio, Vice President and Event Director, NanoBusiness Alliance. “I’m excited to be presenting at Scott Livingston’s new event, with a focus on the tremendous opportunities for nanotechnology in the field of healthcare and life science.”
The summit is a unique and by invitation-only conference designed around three important global issues for investors:
- Drug Discovery and Development: Early to Mid-Stage
- Diagnostics: Valuation and Future Directions
- Global and Emerging Investment Opportunities
Invitees include CEOs, CFOs, COOs for a broad range of pharmaceutical, diagnostic, and platform technology companies, a select number of US and International VCs and PEs, along with key policy makers and federal science and regulatory agencies.
“Our Healthcare & Life Sciences Summit has been designed to bring together key stakeholders from pharmaceutical, capital investment, business strategy and federal science and regulatory segments,” said Scott Livingston, managing director of Axiom Capital Management, and head of the Livingston Group, a division within Axiom that focuses on nanotechnology. “Due to its exclusive nature, we can assure that in addition to helping attendees identify key trends, the event will provide for significant opportunities among participants for deal making.”
For information on registering for the Livingston Healthcare & Life Sciences Summit, please contact Jonathan Mason at [email protected]